Paraneoplastic syndromes (PSN) involve tumor activities beyond direct invasion. Research highlights hormones like pro-adrenocorticotropic hormone (pro-ACTH) and antidiuretic hormone (ADH) as key indicators.
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
Area of Science:
Endocrinology and Oncology
Tumor Biology
Syndromic Manifestations
Context:
Paraneoplasia encompasses tumor effects not directly caused by tumor invasion or burden.
Research in paraneoplastic syndromes (PSN) focuses on tumor-secreted hormones.
Understanding diverse PSN, including neurological, hematological, renal, cutaneous, and gastrointestinal, is crucial.
Purpose:
To investigate the hormonal activities associated with paraneoplasia.
To detail characteristic features and syndromes linked to specific tumors.
To differentiate various paraneoplastic syndromes, particularly those affecting the nervous system, hematopoiesis, kidneys, skin, and gastrointestinal tract.
Summary:
Paraneoplastic syndromes (PSN) are indirect effects of tumors, often involving hormone production.
Key hormones studied include pro-adrenocorticotropic hormone (pro-ACTH) and its subgroups, antidiuretic hormone (ADH), gonadotropins, human placental lactogen (HPL), somatotropic hormone (STH), and prolactin.
Distinctive syndromes associated with specific tumors are identified, with a focus on neurological, hematological, and organ-specific manifestations.
Impact:
Advances understanding of the complex relationship between tumors and systemic effects.
Provides insights into the diagnostic and prognostic value of hormonal markers in oncology.
Facilitates the characterization and differentiation of rare paraneoplastic syndromes.